<DOC>
	<DOC>NCT00111709</DOC>
	<brief_summary>The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.</brief_summary>
	<brief_title>Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Female patient at least 18 years old Patient has menses approximately monthly Patient has at least a 5 month history of migraine and at least a 6 month history of menstrual migraine Pregnant and/or nursing Cardiovascular disease Uncontrolled hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>